07/07/2025
4:23 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/09/2025
4:23 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
DOW GEOFFREY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
7:53 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
XU CHERYL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
2:10 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject)
60 Degrees Pharmaceuticals (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025
1:57 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject)
60 Degrees Pharmaceuticals (Subject)
Ayrton Capital LLC (Filed by)
| Form SCHEDULE 13G | |
04/09/2025
7:31 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2025
11:15 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form EFFECT | |
02/14/2025
4:21 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject)
60 Degrees Pharmaceuticals (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/11/2025
4:23 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/11/2025
3:53 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject)
60 Degrees Pharmaceuticals (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
02/06/2025
9:04 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 424B5 | |
Get the Latest News and Ratings for SXTPW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for 60 Degrees Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/03/2025
3:05 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject)
60 Degrees Pharmaceuticals (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
01/30/2025
4:30 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2025
7:28 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 424B5 | |
01/24/2025
3:51 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
MILLER TYRONE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:52 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
DOW GEOFFREY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:58 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
MILLER TYRONE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
4:00 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
DOW GEOFFREY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:05 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
7:35 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
XU CHERYL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
4:07 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
DOW GEOFFREY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
5:14 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
DOW GEOFFREY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
12:44 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:01 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject)
60 Degrees Pharmaceuticals (Subject)
Knight Therapeutics Inc (Filed by)
| Form SC 13G/A | |
11/06/2024
4:26 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
2:46 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form DEF 14A | |
10/08/2024
7:17 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
9:56 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form PRE 14A | |
09/30/2024
11:15 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form EFFECT | |
09/19/2024
3:30 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/11/2024
3:46 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer)
60 Degrees Pharmaceuticals (Issuer)
XU CHERYL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
2:59 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
9:29 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
11:03 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:15 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
12:21 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 424B5 | |
07/24/2024
4:05 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 424B5 | |
07/22/2024
10:23 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 424B5 | |
07/18/2024
11:15 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form EFFECT | |
07/16/2024
4:28 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
4:02 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer)
60 Degrees Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants (Ad) Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents.
With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside. Get the name of Buffett’s likely gold target here |
